The landscape of dementia diagnosis has developed considerably with the appearance of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based tests which can detect Alzheimer's pathology yrs in advance of indicators emerge. Though these technological advancements depict exceptional development in being familiar with neurodegenerative disorders, t... https://edwardk420jsb8.wikitron.com/user